IN8bio, Inc.
INAB
$1.10
-$0.08-6.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 21.86% | 30.79% | 36.13% | 35.19% | 25.25% |
| Total Depreciation and Amortization | -29.53% | -13.37% | -5.80% | 3.95% | 12.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.22% | -40.49% | -36.79% | -39.64% | -9.85% |
| Change in Net Operating Assets | 126.82% | -186.98% | 173.51% | 106.27% | -923.64% |
| Cash from Operations | 16.48% | 24.88% | 47.36% | 41.53% | 30.05% |
| Capital Expenditure | -633.33% | 92.24% | -- | 85.40% | 89.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -633.33% | 92.24% | -- | 85.40% | 89.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 54.77% | 30.81% | 12.72% | -7.09% | -15.56% |
| Issuance of Common Stock | -6.72% | 31.42% | 94.67% | 26.42% | 11.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 167.04% | 100.00% |
| Cash from Financing | -4.99% | 33.76% | 101.90% | 30.50% | 11.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 53.43% | 998.03% | 256.88% | 175.75% | 144.62% |